MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma
Sonia V. del Rincón(McGill University)
Cited by 76
Related Papers
Spatially mapping the immune landscape of melanoma using imaging mass cytometry
|Science Immunology|2022|131
The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma
|International Journal of Molecular Sciences|2020|37
Raw CyTOF images associated with Moldoveanu et al. 2022, Science Immunology
|Zenodo (CERN European Organization for Nuclear Research)|2022|1
Multi-platform characterization of cutaneous melanoma from patients treated with immune checkpoint inhibitors.
|Journal of Clinical Oncology|2018|0